• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Vatica Health Acquires CareSync’s Technology to Expand Value-Based Care Capabilities

Share:

January 14, 2019

Vatica Health, the leader in provider- centric risk adjustment and clinical quality solutions for health plans and risk-bearing entities, today announced it has closed on its acquisition of CareSync’s technology.

Since its founding in 2011, CareSync had raised over $50 million to develop a best-in-class technology platform for coordinating care and improving outcomes of people suffering from chronic conditions. Vatica will incorporate CareSync’s technology to broaden its payer and provider product offerings.

“This acquisition accelerates Vatica’s vision to create a robust platform leveraging proprietary technology combined with clinical teams to deliver value-based care, improve quality measures, and optimize financial results,” said Hassan Rifaat, MD, Chief Executive Officer of Vatica Health. As part of the transaction, a number of former CareSync employees have also joined Vatica.

Great Hill Partners purchased a majority stake of Vatica in April 2018, and the acquisition of CareSync’s

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

intellectual property represents Vatica’s first transaction under Great Hill ownership.

“We are grateful for the strong support from our majority investor, Great Hill Partners. With their capital commitment and financial support, we will remain highly active pursuing M&A opportunities focused on expanding our innovative solutions for both payers and providers,” commented Steve Zuckerman, Vatica’s Co-Founder and Chief Strategy Officer.

Date: January 15, 2019

Source: MarketWatch

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Paratek Pharmaceuticals Up 20% On Takeout Speculation – ReportParatek Pharmaceuticals Up 20% On Takeout Speculation – Report
  • Saint-Gobain Life Sciences Acquires Equflow B.V.Saint-Gobain Life Sciences Acquires Equflow B.V.
  • Amazon’s One Medical announces three new partnershipsAmazon’s One Medical announces three new partnerships
  • SAIC Unloads Logistics & Supply Chain Business Through Sale to ASRC Federal for $350MSAIC Unloads Logistics & Supply Chain Business Through Sale to ASRC Federal for $350M
  • Allergan Aesthetics to Acquire Soliton, Expanding Body Contouring PortfolioAllergan Aesthetics to Acquire Soliton, Expanding Body Contouring Portfolio
  • Autism Learning Partners and Cognoa Announce Partnership to Enable Earlier Access to CareAutism Learning Partners and Cognoa Announce Partnership to Enable Earlier Access to Care
  • 6 HIEs Form New Consortium to Drive Population Health Improvements Via Data Sharing Interoperability6 HIEs Form New Consortium to Drive Population Health Improvements Via Data Sharing Interoperability
  • Lantern Pharma Reacquires Rights to Phase 2 Clinical Trial in Metastatic Prostate Cancer and Global Development & Commercialization of Irofulven (lP-100) from Allarity Therapeutics A/SLantern Pharma Reacquires Rights to Phase 2 Clinical Trial in Metastatic Prostate Cancer and Global Development & Commercialization of Irofulven (lP-100) from Allarity Therapeutics A/S

Trending This Week

  • Scotland’s Life Sciences Strategy Targets £25bn
  • Nectar Lifesciences Shares Surge on Buyback News
  • SUPRIYA Lifescience Strategic Growth Through Advanced Manufacturing
  • Supriya Lifescience Stock Analysis and Outlook
  • Investment Guide Buy Sell Hold Five Stocks
  • Eiko Lifesciences Financial Performance Analysis 2025

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications